{{Rsnum
|rsid=1876487
|Gene=SPR
|Chromosome=2
|position=72887223
|Orientation=minus
|GMAF=0.3802
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=SPR
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 43.1 | 44.6 | 12.3
| HCB | 91.1 | 8.9 | 0.0
| JPT | 93.2 | 6.8 | 0.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 91.1 | 8.9 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19415819
|Title=Polymorphisms of sepiapterin reductase gene alter promoter activity and may influence risk of bipolar disorder
}}

{{omim
|desc=PARKINSON DISEASE 3, AUTOSOMAL DOMINANT LEWY BODY; PARK3
|id=602404
|rsnum=1876487
}}

{{PMID|14663042}} A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study.

{{PMID|16443856|OA=1
}} The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson's disease in European populations.

{{PMID|17270157|OA=1
}} Sepiapterin reductase expression is increased in Parkinson's disease brain tissue.

{{PMID|21782285}} Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}